Abstract:Objective To observe the effects of Dexmedetomidine preconditioning and postconditioning on myocardial ischemia-reperfusion injury during cardiopulmonary bypass. Methods Totally 120 patients who underwent mitral valve or aortic valve replacement surgery were randomly divided into three groups (n?=?40): dexmedetomidine preconditioning group (pre-D group), the dexmedetomidine postconditioning group (post-D group), and dexmedetomidine preconditioning combined with postconditioning group (pre-post-D group). Dexmedetomidine preconditioning was achieved by intravenous injection of dexmedetomidine (1?μg/kg) 30 minutes before aortic cross-clamping. Dexmedetomidine postconditioning was achieved by intravenous injection of dexmedetomidine (0.2-1.0?μg/kg) 30 minutes before aorta declamping. Clinical characters were recorded including serum TNF-α, IL-6, CK-MB, and cTnI, MAP, HR, and BIS were recorded at various time point T0, 15 minutes after aorta de-clamping (T1), end of bypass (T2), 4 h (T3), 16 h (T4), 36 h (T5) and 72 h (T6) postoperatively. The incidence of spontaneous recovery of heart beat after aorta de-clamping and ventricular arrhythmia, the ante-parallel cycle time, aorta clamping time and post-parallel cycle time were also recorded. Results No obvious differences in the values of HR and MAP was identified. Compared with group preD and group posD, the serum levels of TNF-α, CK-MB and IL-6 were decreased in pre-post-D group at T1, T2, T3, T4, T5, T6. Conclusions Dexmedetomidine preconditioning combined with postconditioning may offer better myocardial protective effect against ischemia-reperfusion injury probably through downregulating inflammatory response.